Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the International Conference on Frailty & Sarcopenia Research (ICSFR) Task Force has published a key paper on Aging Frailty, a worldwide public health priority that is increasing in severity as human populations age.
August 20, 2018
· 3 min read